241 related articles for article (PubMed ID: 19710188)
1. The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers.
Setchell KD; Zhao X; Jha P; Heubi JE; Brown NM
Am J Clin Nutr; 2009 Oct; 90(4):1029-37. PubMed ID: 19710188
[TBL] [Abstract][Full Text] [Related]
2. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.
Setchell KD; Clerici C; Lephart ED; Cole SJ; Heenan C; Castellani D; Wolfe BE; Nechemias-Zimmer L; Brown NM; Lund TD; Handa RJ; Heubi JE
Am J Clin Nutr; 2005 May; 81(5):1072-9. PubMed ID: 15883431
[TBL] [Abstract][Full Text] [Related]
3. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women.
Setchell KD; Faughnan MS; Avades T; Zimmer-Nechemias L; Brown NM; Wolfe BE; Brashear WT; Desai P; Oldfield MF; Botting NP; Cassidy A
Am J Clin Nutr; 2003 Feb; 77(2):411-9. PubMed ID: 12540402
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women.
Setchell KD; Zhao X; Shoaf SE; Ragland K
J Nutr; 2009 Nov; 139(11):2037-43. PubMed ID: 19776178
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.
Vergne S; Titier K; Bernard V; Asselineau J; Durand M; Lamothe V; Potier M; Perez P; Demotes-Mainard J; Chantre P; Moore N; Bennetau-Pelissero C; Sauvant P
J Pharm Biomed Anal; 2007 Mar; 43(4):1488-94. PubMed ID: 17110073
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic Comparison of Soy Isoflavone Extracts in Human Plasma.
Rodríguez-Morató J; Farré M; Pérez-Mañá C; Papaseit E; Martínez-Riera R; de la Torre R; Pizarro N
J Agric Food Chem; 2015 Aug; 63(31):6946-53. PubMed ID: 26186408
[TBL] [Abstract][Full Text] [Related]
8. Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor β-agonist being developed for the treatment of menopausal symptoms.
Jackson RL; Greiwe JS; Desai PB; Schwen RJ
Menopause; 2011 Feb; 18(2):185-93. PubMed ID: 21341397
[TBL] [Abstract][Full Text] [Related]
9. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
10. Development of chiral liquid chromatography-tandem mass spectrometry isotope dilution methods for the determination of unconjugated and total S-equol in human plasma and urine.
Plomley JB; Jackson RL; Schwen RJ; Greiwe JS
J Pharm Biomed Anal; 2011 Apr; 55(1):125-34. PubMed ID: 21247718
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods.
Cassidy A; Brown JE; Hawdon A; Faughnan MS; King LJ; Millward J; Zimmer-Nechemias L; Wolfe B; Setchell KD
J Nutr; 2006 Jan; 136(1):45-51. PubMed ID: 16365057
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: a randomized, double-blind, crossover study.
Rüfer CE; Bub A; Möseneder J; Winterhalter P; Stürtz M; Kulling SE
Am J Clin Nutr; 2008 May; 87(5):1314-23. PubMed ID: 18469255
[TBL] [Abstract][Full Text] [Related]
13. Dairy consumption is a significant correlate of urinary equol concentration in a representative sample of US adults.
Frankenfeld CL
Am J Clin Nutr; 2011 May; 93(5):1109-16. PubMed ID: 21389178
[TBL] [Abstract][Full Text] [Related]
14. Equol: history, chemistry, and formation.
Setchell KD; Clerici C
J Nutr; 2010 Jul; 140(7):1355S-62S. PubMed ID: 20519412
[TBL] [Abstract][Full Text] [Related]
15. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
Hall WL; Vafeiadou K; Hallund J; Bügel S; Koebnick C; Reimann M; Ferrari M; Branca F; Talbot D; Dadd T; Nilsson M; Dahlman-Wright K; Gustafsson JA; Minihane AM; Williams CM
Am J Clin Nutr; 2005 Dec; 82(6):1260-8; quiz 1365-6. PubMed ID: 16332659
[TBL] [Abstract][Full Text] [Related]
16. Equol: pharmacokinetics and biological actions.
Setchell KD; Clerici C
J Nutr; 2010 Jul; 140(7):1363S-8S. PubMed ID: 20519411
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako).
Watanabe S; Yamaguchi M; Sobue T; Takahashi T; Miura T; Arai Y; Mazur W; Wähälä K; Adlercreutz H
J Nutr; 1998 Oct; 128(10):1710-5. PubMed ID: 9772140
[TBL] [Abstract][Full Text] [Related]
18. Increased probiotic yogurt or resistant starch intake does not affect isoflavone bioavailability in subjects consuming a high soy diet.
Larkin TA; Price WE; Astheimer LB
Nutrition; 2007 Oct; 23(10):709-18. PubMed ID: 17656069
[TBL] [Abstract][Full Text] [Related]
19. Food matrix and isoflavones bioavailability in early post menopausal women: a European clinical study.
Chanteranne B; Branca F; Kaardinal A; Wahala K; Braesco V; Ladroite P; Brouns F; Coxam V
Clin Interv Aging; 2008; 3(4):711-8. PubMed ID: 19281063
[TBL] [Abstract][Full Text] [Related]
20. Optimal cut-off value for equol-producing status in women: The Japan Nurses' Health Study urinary isoflavone concentration survey.
Ideno Y; Hayashi K; Nakajima-Shimada J; Onizuka Y; Kishi M; Ueno T; Uchiyama S
PLoS One; 2018; 13(7):e0201318. PubMed ID: 30048499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
